Norway's Crown Princess Mette-Marit has successfully undergone a lung transplant at Rikshospitalet in Oslo, marking a critical milestone in her battle against pulmonary fibrosis. The 52-year-old royal, who was diagnosed with the progressive lung disease in 2018, received the transplant on June 17, 2026, after being on the waiting list for nearly two weeks. The royal palace confirmed the procedure's success and stated she will remain hospitalized for several weeks during recovery. Der Spiegel+2
The double lung transplant was performed as a last-resort treatment for the princess's rare pulmonary fibrosis, a condition that had severely limited her lung function. Prior to the surgery, she had been relying on an oxygen device during public appearances. Medical experts note the unusually short waiting period for the organ match, which significantly improved her prognosis. Toronto Star+2
Crown Prince Haakon has adjusted his schedule to support his wife during her recovery, according to palace officials. The Norwegian royal family expressed gratitude to the medical team and organ donor, emphasizing the importance of organ donation awareness. The announcement brought relief to supporters following years of health struggles and recent royal family scandals. Tagesschau.de+2
Princess Mette-Marit is expected to remain under close medical supervision for several weeks at Rikshospitalet. Doctors report the procedure went smoothly, but caution that the coming months will be critical for monitoring organ rejection risks. The palace has requested privacy during this period while providing periodic updates on her progress. Die Welt+2
News of the successful transplant has dominated Norwegian media, with well-wishes pouring in from across the country. The princess's openness about her health struggles has raised awareness about pulmonary fibrosis and organ donation. Royal commentators highlight this as a positive development amid recent controversies surrounding the monarchy. Süddeutsche Zeitung+2